28.23
-1.30 (-4.40%)
| Penutupan Terdahulu | 29.53 |
| Buka | 29.31 |
| Jumlah Dagangan | 384,938 |
| Purata Dagangan (3B) | 711,754 |
| Modal Pasaran | 1,620,026,496 |
| Harga / Pendapatan (P/E TTM) | 11.25 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.33 |
| Harga / Jualan (P/S) | 2.40 |
| Harga / Buku (P/B) | 2.58 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Apr 2025 - 2 May 2025 |
| Margin Keuntungan | 20.36% |
| Margin Operasi (TTM) | 27.69% |
| EPS Cair (TTM) | 2.51 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 19.50% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 85.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 27.52% |
| Nisbah Semasa (MRQ) | 3.31 |
| Aliran Tunai Operasi (OCF TTM) | 219.82 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 143.91 M |
| Pulangan Atas Aset (ROA TTM) | 13.17% |
| Pulangan Atas Ekuiti (ROE TTM) | 25.84% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Harmony Biosciences Holdings, I | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -4.0 |
| Purata | 0.75 |
|
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 11.63% |
| % Dimiliki oleh Institusi | 98.14% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Valor Management Llc | 31 Dec 2024 | 6,618,033 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 70.00 (HC Wainwright & Co., 147.96%) | Beli |
| Median | 50.00 (77.12%) | |
| Rendah | 44.00 (Mizuho, 55.86%) | Beli |
| Purata | 53.40 (89.16%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 31.85 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| UBS | 28 Apr 2025 | 48.00 (70.03%) | Beli | 29.61 |
| Needham | 10 Apr 2025 | 50.00 (77.12%) | Beli | 28.99 |
| 08 Apr 2025 | 50.00 (77.12%) | Beli | 28.13 | |
| HC Wainwright & Co. | 08 Apr 2025 | 70.00 (147.96%) | Beli | 28.13 |
| 27 Feb 2025 | 70.00 (147.96%) | Beli | 32.75 | |
| Mizuho | 18 Mar 2025 | 44.00 (55.86%) | Beli | 34.78 |
| 20 Feb 2025 | 42.00 (48.78%) | Beli | 34.89 | |
| Deutsche Bank | 11 Feb 2025 | 55.00 (94.83%) | Beli | 37.74 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |